Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: A randomized controlled trial

Atherosclerosis

Volumn 217, Issue 1, 2011, Pages 240-248

  Schlager, Oliver ^a   Giurgea, Aura ^a   Schuhfried, Othmar ^a   Seidinger, Daniela ^a   Hammer, Alexandra ^a   Gröger, Marion ^b   Fialka Moser, Veronika ^a   Gschwandtner, Michael ^a   Koppensteiner, Renate ^a   Steiner, Sabine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

Asymmetric dimethylarginine; Endothelial progenitor cells; Peripheral arterial disease; Supervised exercise training

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CD133 ANTIGEN; CD34 ANTIGEN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N(G),N(G) DIMETHYLARGININE; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANGIOGENESIS; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; COLONY FORMING UNIT; CULTURE TECHNIQUE; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KINESIOTHERAPY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SUPERVISED EXERCISETRAINING; WALKING;

AGED; ARGININE; CELL MOVEMENT; CHEMOKINE CXCL12; ENDOTHELIAL CELLS; EXERCISE; FEMALE; FLOW CYTOMETRY; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PERIPHERAL ARTERIAL DISEASE; STEM CELLS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960223602     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.03.018     Document Type: Article

References (37)

1. Diehm C., Kareem S., Lawall H. Epidemiology of peripheral arterial disease. Vasa 2004, 33:183-189.
2. Caro J., Migliaccio-Walle K., Ishak K.J., Proskorovsky I. The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord 2005, 5:14.
3. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007, 33(Suppl 1):S1-75.
4. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001, 344:1608-1621.
5. Clarkson P., Montgomery H.E., Mullen M.J., et al. Exercise training enhances endothelial function in young men. J Am Coll Cardiol 1999, 33:1379-1385.
6. Laufs U., Werner N., Link A., et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004, 109:220-226.
7. Richter B., Niessner A., Penka M., et al. Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events. Thromb Haemost 2005, 94:1306-1311.
8. Steiner S., Niessner A., Ziegler S., et al. Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis 2005, 181:305-310.
9. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells vascular function cardiovascular risk. N Engl J Med 2003, 348:593-600.
10. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
11. Umemura T., Soga J., Hidaka T., et al. Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells. Am J Hypertens 2008, 21:1203-1209.
12. Jaumdally R.J., Goon P.K., Varma C., Blann A.D., Lip G.Y. Effects of atorvastatin on circulating CD34+/CD133+/CD45-progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus. J Intern Med 2009.
13. Sandri M., Adams V., Gielen S., et al. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 2005, 111:3391-3399.
14. Mittermayer F., Krzyzanowska K. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Arterioscler Thromb Vasc Biol 2006, 26:2536-2540.
15. Aicher A., Heeschen C., Mildner-Rihm C., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003, 9:1370-1376.
16. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
17. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006, 47:1239-1312.
18. Cachovan M., Rogatti W., Creutzig A., et al. Treadmill testing for evaluation of claudication: comparison of constant-load and graded-exercise tests. Eur J Vasc Endovasc Surg 1997, 14:238-243.
19. Stewart K.J., Hiatt W.R., Regensteiner J.G., Hirsch A.T. Exercise training for claudication. N Engl J Med 2002, 347:1941-1951.
20. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.
21. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001, 108:391-397.
22. Grisar J., Aletaha D., Steiner C.W., et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 2005, 111:204-211.
23. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-7.
24. Steiner S., Winkelmayer W.C., Kleinert J., et al. Endothelial progenitor cells in kidney transplant recipients. Transplantation 2006, 81:599-606.
25. Dormandy J., Heeck L., Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg 1999, 12:123-137.
26. Yoder M.C., Mead L.E., Prater D., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.
27. Rehman J., Li J., Parvathaneni L., Karlsson G., et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 2004, 43:2314-2318.
28. Findley C.M., Mitchell R.G., Duscha B.D., Annex B.H., Kontos C.D. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol 2008, 52:387-393.
29. Johnson C., Sung H.J., Lessner S.M., Fini M.E., Galis Z.S. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. Circ Res 2004, 94:262-268.
30. Huang P.H., Chen Y.H., Wang C.H., et al. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009, 29:1179-1184.
31. Yu J.X., Huang X.F., Lv W.M., et al. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. J Vasc Surg 2009, 50:608-616.
32. van Weel V., Seghers L., de Vries M.R., et al. Expression of vascular endothelial growth factor, stromal cell-derived factor-1, and CXCR4 in human limb muscle with acute and chronic ischemia. Arterioscler Thromb Vasc Biol 2007, 27:1426-1432.
33. Kojda G., Cheng Y.C., Burchfield J., Harrison D.G. Dysfunctional regulation of endothelial nitric oxide synthase (eNOS) expression in response to exercise in mice lacking one eNOS gene. Circulation 2001, 103:2839-2844.
34. Boger R.H. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 2006, 38:126-136.
35. Boger R.H., Bode-Boger S.M., Szuba A., et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998, 98:1842-1847.
36. Leng G.C., Fowler B., Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2000, CD000990.
37. Nicolai S.P., Hendriks E.J., Prins M.H., Teijink J.A. Optimizing supervised exercise therapy for patients with intermittent claudication. J Vasc Surg 2010, 52:1226-1233.